Literature DB >> 22417114

Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference.

K Ezzedine1, H W Lim, T Suzuki, I Katayama, I Hamzavi, C C E Lan, B K Goh, T Anbar, C Silva de Castro, A Y Lee, D Parsad, N van Geel, I C Le Poole, N Oiso, L Benzekri, R Spritz, Y Gauthier, S K Hann, M Picardo, A Taieb.   

Abstract

During the 2011 International Pigment Cell Conference (IPCC), the Vitiligo European Taskforce (VETF) convened a consensus conference on issues of global importance for vitiligo clinical research. As suggested by an international panel of experts, the conference focused on four topics: classification and nomenclature; definition of stable disease; definition of Koebner's phenomenon (KP); and 'autoimmune vitiligo'. These topics were discussed in seven working groups representing different geographical regions. A consensus emerged that segmental vitiligo be classified separately from all other forms of vitiligo and that the term 'vitiligo' be used as an umbrella term for all non-segmental forms of vitiligo, including 'mixed vitiligo' in which segmental and non-segmental vitiligo are combined and which is considered a subgroup of vitiligo. Further, the conference recommends that disease stability be best assessed based on the stability of individual lesions rather than the overall stability of the disease as the latter is difficult to define precisely and reliably. The conference also endorsed the classification of KP for vitiligo as proposed by the VETF (history based, clinical observation based, or experimentally induced). Lastly, the conference agreed that 'autoimmune vitiligo' should not be used as a separate classification as published evidence indicates that the pathophysiology of all forms of vitiligo likely involves autoimmune or inflammatory mechanisms.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2012        PMID: 22417114      PMCID: PMC3511780          DOI: 10.1111/j.1755-148X.2012.00997.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  59 in total

1.  The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force.

Authors:  Alain Taïeb; Mauro Picardo
Journal:  Pigment Cell Res       Date:  2007-02

Review 2.  Autoimmune etiology of generalized vitiligo.

Authors:  I Caroline Le Poole; Rosalie M Luiten
Journal:  Curr Dir Autoimmun       Date:  2008

Review 3.  Clinical features of vitiligo.

Authors:  S K Hann; Y K Park; W H Chun
Journal:  Clin Dermatol       Date:  1997 Nov-Dec       Impact factor: 3.541

4.  Clinical features and course of type A and type B vitiligo.

Authors:  M Koga; T Tango
Journal:  Br J Dermatol       Date:  1988-02       Impact factor: 9.302

5.  Immunopathology of vitiligo vulgaris, Sutton's leukoderma and melanoma-associated vitiligo in relation to steroid effects. II. The IgG and C3 deposits in the skin.

Authors:  H Uda; M Takei; Y Mishima
Journal:  J Cutan Pathol       Date:  1984-04       Impact factor: 1.587

6.  Superimposed segmental manifestation of polygenic skin disorders.

Authors:  Rudolf Happle
Journal:  J Am Acad Dermatol       Date:  2007-10       Impact factor: 11.527

7.  Standard guidelines of care for vitiligo surgery.

Authors:  Davinder Parsad; Somesh Gupta
Journal:  Indian J Dermatol Venereol Leprol       Date:  2008-01       Impact factor: 2.545

8.  The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis.

Authors:  M Cario-André; C Pain; Y Gauthier; A Taïeb
Journal:  Pigment Cell Res       Date:  2007-10

9.  From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo.

Authors:  Karin U Schallreuter; Christian Krüger; Brigitte A Würfel; Angela Panske; John M Wood
Journal:  Int J Dermatol       Date:  2008-07       Impact factor: 2.736

Review 10.  Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis.

Authors:  Richard A Spritz
Journal:  J Invest Dermatol       Date:  2011-10-13       Impact factor: 8.551

View more
  91 in total

1.  Oxidative stress-induced overexpression of miR-25: the mechanism underlying the degeneration of melanocytes in vitiligo.

Authors:  Q Shi; W Zhang; S Guo; Z Jian; S Li; K Li; R Ge; W Dai; G Wang; T Gao; C Li
Journal:  Cell Death Differ       Date:  2015-08-28       Impact factor: 15.828

2.  Autoimmune vitiligo is associated with gain-of-function by a transcriptional regulator that elevates expression of HLA-A*02:01 in vivo.

Authors:  Masahiro Hayashi; Ying Jin; Daniel Yorgov; Stephanie A Santorico; James Hagman; Tracey M Ferrara; Kenneth L Jones; Giulio Cavalli; Charles A Dinarello; Richard A Spritz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-19       Impact factor: 11.205

3.  Systemic analyses of immunophenotypes of peripheral T cells in non-segmental vitiligo: implication of defective natural killer T cells.

Authors:  Li Zhou; Kai Li; Yu-Ling Shi; Iltefat Hamzavi; Tian-Wen Gao; Marsha Henderson; Richard H Huggins; Oma Agbai; Bassel Mahmoud; Xiaofan Mi; Henry W Lim; Qing-Sheng Mi
Journal:  Pigment Cell Melanoma Res       Date:  2012-07-12       Impact factor: 4.693

Review 4.  Melanoma-associated leukoderma - immunology in black and white?

Authors:  Hadas Prag Naveh; Uma N M Rao; Lisa H Butterfield
Journal:  Pigment Cell Melanoma Res       Date:  2013-10-09       Impact factor: 4.693

5.  A New View of Vitiligo: Looking at Normal-Appearing Skin.

Authors:  Mauro Picardo; Emanuela Bastonini
Journal:  J Invest Dermatol       Date:  2015-07       Impact factor: 8.551

Review 6.  Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.

Authors:  Katia Boniface; Julien Seneschal; Mauro Picardo; Alain Taïeb
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

7.  MicroRNA-211 Regulates Oxidative Phosphorylation and Energy Metabolism in Human Vitiligo.

Authors:  Anupama Sahoo; Bongyong Lee; Katia Boniface; Julien Seneschal; Sanjaya K Sahoo; Tatsuya Seki; Chunyan Wang; Soumen Das; Xianlin Han; Michael Steppie; Sudipta Seal; Alain Taieb; Ranjan J Perera
Journal:  J Invest Dermatol       Date:  2017-05-11       Impact factor: 8.551

8.  Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.

Authors:  Roselyne Y Wagner; Flavie Luciani; Muriel Cario-André; Alain Rubod; Valérie Petit; Laila Benzekri; Khaled Ezzedine; Sébastien Lepreux; Eirikur Steingrimsson; A Taieb; Yvon Gauthier; Lionel Larue; Véronique Delmas
Journal:  J Invest Dermatol       Date:  2015-01-29       Impact factor: 8.551

Review 9.  Vitiligo: what's new in the psycho-neuro-endocrine-immune connection and related treatments.

Authors:  Torello Lotti; Matteo Zanardelli; Angelo Massimiliano D'Erme
Journal:  Wien Med Wochenschr       Date:  2014-07-25

10.  Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation.

Authors:  Jonathan M Eby; Hee-Kap Kang; Jared Klarquist; Shilpak Chatterjee; Jeffrey A Mosenson; Michael I Nishimura; Elizabeth Garrett-Mayer; B Jack Longley; Victor H Engelhard; Shikhar Mehrotra; I Caroline Le Poole
Journal:  Pigment Cell Melanoma Res       Date:  2014-07-21       Impact factor: 4.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.